Introduction
COVID-19 treatment development is moving at an unprecedented pace across the world and resulting therapeutics may be critical to reducing disease burden and pressure on the health system. This memo provides a brief review of accelerated development efforts, the types of treatments being studied, and information about outcomes of select studies.
Early results and expedited regulatory pathways have already sparked discussions about availability of effective treatments as they emerge. The promise of reducing mortality, morbidity, and burden on the health care system while awaiting a vaccine is driving unprecedented partnerships and global investments.
All NGA COVID-19 memos can be found here, or visit COVID-19: What You Need To Know for current information on actions States/Territories are taking to address the COVID-19 pandemic; as well as advocacy, policy, and guidance documents for protecting public health and the economy.
